Quick Takeaways
- Brian Piekos has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,191,821.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Brian Piekos
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Brian Piekos is at least $2,191,821 dollars as of 24 Feb 2026. Brian Piekos is the CFO of Gemini Therapeutics, Inc. /DE and owns shares of Disc Medicine, Inc. (IRON) stock worth about $1.19M. Brian Piekos is the Chief Financial Officer of KalVista Pharmaceuticals, Inc. and owns shares of KalVista Pharmaceuticals, Inc. (KALV) stock worth about $1M.
- Signature
- /s/ Benjamin L. Palleiko, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Brian Piekos and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Gemini Therapeutics, Inc. /DE ($1,191,655).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Brian Piekos
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IRON | Gemini Therapeutics, Inc. /DE | Cfo | $1,191,655 | 31 May 2022 | ||
| KALV | KalVista Pharmaceuticals, Inc. | Chief Financial Officer | $1,000,166 | -$87,646 | -8.1% | 21 Feb 2026 |
| ELTX | Elicio Therapeutics, Inc. | Chief Financial Officer | 01 Feb 2024 |
Insider Transactions Reported by Brian Piekos:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.